201 related articles for article (PubMed ID: 26352542)
1. The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications.
Malcovati L; Ambaglio I; Elena C
Curr Opin Oncol; 2015 Nov; 27(6):551-9. PubMed ID: 26352542
[TBL] [Abstract][Full Text] [Related]
2. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.
Malcovati L; Papaemmanuil E; Ambaglio I; Elena C; Gallì A; Della Porta MG; Travaglino E; Pietra D; Pascutto C; Ubezio M; Bono E; Da Vià MC; Brisci A; Bruno F; Cremonesi L; Ferrari M; Boveri E; Invernizzi R; Campbell PJ; Cazzola M
Blood; 2014 Aug; 124(9):1513-21. PubMed ID: 24970933
[TBL] [Abstract][Full Text] [Related]
3. Cohesin mutations in myeloid malignancies made simple.
Viny AD; Levine RL
Curr Opin Hematol; 2018 Mar; 25(2):61-66. PubMed ID: 29278534
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
Hartmann L; Metzeler KH
Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
[TBL] [Abstract][Full Text] [Related]
5. [Genomic aberrations in myelodysplastic syndromes and related disorders].
Makishima H
Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
Jhanwar SC
Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
[TBL] [Abstract][Full Text] [Related]
7. Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms.
Negri G; Crescenzi B; Colombo EA; Fontana L; Barba G; Arcioni F; Gervasini C; Mecucci C; Larizza L
Br J Haematol; 2015 Nov; 171(4):557-65. PubMed ID: 26306619
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic biomarkers in myeloid malignancies.
Matynia AP; Szankasi P; Shen W; Kelley TW
Arch Pathol Lab Med; 2015 May; 139(5):594-601. PubMed ID: 25152312
[TBL] [Abstract][Full Text] [Related]
9. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
[TBL] [Abstract][Full Text] [Related]
11. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Tiu RV; Sekeres MA
Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.
Zhang L; Padron E; Lancet J
Leuk Res; 2015 Jan; 39(1):6-17. PubMed ID: 25465125
[TBL] [Abstract][Full Text] [Related]
13. [Epigenetic dysregulation in myelodysplastic syndrome].
Sashida G; Iwama A
Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.
Rüter B; Wijermans PW; Lübbert M
Int J Hematol; 2004 Aug; 80(2):128-35. PubMed ID: 15481440
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic molecular pathology of lymphatic and myeloid neoplasms].
Klapper W; Kreipe H
Pathologe; 2015 Mar; 36(2):164-70. PubMed ID: 25809654
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
Nakajima H
Intern Med; 2021 Jan; 60(1):15-23. PubMed ID: 32009100
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
Gao J; Gong S; Chen YH
Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
19. Genetics of myeloid malignancies: pathogenetic and clinical implications.
Fröhling S; Scholl C; Gilliland DG; Levine RL
J Clin Oncol; 2005 Sep; 23(26):6285-95. PubMed ID: 16155011
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of myeloid malignancies.
Kitamura T; Inoue D; Okochi-Watanabe N; Kato N; Komeno Y; Lu Y; Enomoto Y; Doki N; Uchida T; Kagiyama Y; Togami K; Kawabata KC; Nagase R; Horikawa S; Hayashi Y; Saika M; Fukuyama T; Izawa K; Oki T; Nakahara F; Kitaura J
Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):389-404. PubMed ID: 25504228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
